^DRG

NYSE Arca Pharmaceutical Index
NYSEUSDEQUITY DELAYED
Last price
1,303.97
▲ 16.18 (1.26%)
MARKET ·

Price

Open
1,287.79
Prev close
1,287.79
Day high
1,313.84
Day low
1,283.97
Volume
Market cap
P/E (TTM)
52W range
923.90 – 1,321.15

Trailing performance

Price return · vs SPY
Returnvs SPY
1W
+5.79% +7.2%
1M
+5.28% +1.6%
3M
+13.82% +10.7%
6M
+9.83% -1.2%
YTD
+15.80% +3.5%
1Y
+37.85% +17.9%
3Y
+42.68% -31.5%
5Y

Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.

Fundamentals

TTM · reported
Market cap
Enterprise value
Revenue (TTM)
Gross profit
EBITDA
Net income
EPS (TTM)
Free cash flow
Total cash
Total debt
Book value / share
Shares outstanding
Float
Short % of float
Dividend yield
Beta (5Y)

Valuation & profitability ratios

Account required
Trailing P/E
Forward P/E
PEG ratio
Price / sales
Price / book
EV / revenue
EV / EBITDA
Gross margin
Operating margin
Profit margin
Return on equity
Return on assets
Debt / equity
Current ratio
Free account required

Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.

Analyst targets & ownership

Account required
Mean target
High target
Low target
Implied upside
Analyst count
Consensus
Strong buy / Buy— / —
Hold
Sell / Strong sell— / —
Held by insiders
Held by institutions
Institutions holding
Free account required

Price targets, consensus spread, insider and institutional ownership.

Moving averages & technicals

Computed from 2Y daily closes
SMA 10
1,263.23
+3.23% from price
SMA 20
1,248.89
+4.41% from price
SMA 50
1,228.15
+6.17% from price
SMA 100
1,177.07
+10.78% from price
SMA 200
1,152.87
+13.11% from price
EMA 12
1,265.27
+3.06% from price
EMA 26
1,247.88
+4.50% from price
EMA 50
1,226.62
+6.31% from price
RSI (14)
63.2
Neutral
MACD (12,26,9)
17.39
Hist 6.33
ATR (14)
26.75
2.05% of price
Realised vol 30D
23.1%
Annualised
Bollinger upper
1,307.84
20, 2σ
Bollinger lower
1,189.94
20, 2σ
50 / 200 cross
Golden
1,228.15 vs 1,152.87
Trend bias
Above 200
+13.11%

Risk profile

Daily returns · 1Y window
Beta vs SPY
0.23
Less volatile than market
Correlation to SPY
0.15
Largely independent
Realised vol 30D
23.1%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-11.7%
Peak to trough
Max drawdown 5Y
-24.5%
Peak to trough
ATR 14
26.75
2.05% of price
Beta (reported)
5Y monthly, from filing

Options chain

Account required
ExpirySpot 1,303.97
Calls
StrikeLastBidAskVolOIIV
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
Puts
StrikeLastBidAskVolOIIV
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
Free account required

Every listed expiry, both sides of the book, with volume, open interest and implied volatility.

PRIVATE STRATEGY · BY QUALIFICATION

The same data. A different seat.

The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.